Development and Validation of a Nomogram to Predict the 180-Day Readmission Risk for Chronic Heart Failure: A

Shanshan Gao1, Gang Yin2, Qing Xia2

  • 1Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College (SUMC), Cardiology, Shantou, China.

Insights

A new nomogram accurately predicts 180-day readmission for chronic heart failure (CHF) patients using five key variables. This tool offers improved prediction for CHF readmissions, aiding clinical decision-making.

Area of Science:

  • Cardiology
  • Medical Informatics

Background:

  • Existing chronic heart failure (CHF) prediction models lack generalizability.
  • There is a need for a widely applicable tool to predict CHF readmissions.

Purpose of the Study:

  • To develop and validate a broadly applicable nomogram for predicting 180-day readmission in CHF patients.

Main Methods:

  • Prospective enrollment of 2,980 CHF patients across two hospitals.
  • Utilized Least Absolute Shrinkage and Selection Operator (Lasso) regression for variable selection from 102 baseline variables.
  • Developed a predictive nomogram using multivariable Cox proportional hazards regression, validated internally and externally.

Main Results:

  • The final nomogram incorporated five variables: history of acute heart failure, emergency department visit, age, blood urea nitrogen level, and beta-blocker usage.
  • The model achieved a concordance index (C-index) of 0.75 for development and 0.73-0.75 for validation datasets.
  • No significant improvement in prediction was observed when additional variables like discharge method or alcohol use were included.

Conclusions:

  • A validated nomogram based on five variables effectively predicts 180-day readmission for CHF patients.
  • This methodology enhances the accuracy of predicting patient readmissions and has broad clinical applications for CHF management.

Related Concept Videos

Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
32
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
74
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
193
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
30
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
52
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
57